Noncatalytic Bruton's tyrosine kinase activates PLCγ2 variants mediating ibrutinib resistance in human chronic lymphocytic leukemia cells

Martin Wist, Laura Meier, Orit Gutman, Jennifer Haas, Sascha Endres, Yuan Zhou, R. Rosler, Sebastian Wiese, Stephan Stilgenbauer, Elias Hobeika,

Journal of Biological Chemistry · 2020 · 33 citations · 78 references

DOIFull text

Open access

Concepts

Abstract

Because catalytically-inactive BTK is insensitive to active-site BTK inhibitors, the mechanism involving the noncatalytic BTK uncovered here may contribute to preexisting reduced sensitivity or even primary resistance of CLL to these drugs.

References

78